What may be required to prevent altitude sickness during ascents above 10,000 feet?

Prepare thoroughly with the Navy Dive Manual Test. Utilize flashcards and multiple choice questions, each offering hints and explanations. Boost your confidence and readiness for success!

The necessity of prophylactic drugs to prevent altitude sickness during ascents above 10,000 feet is rooted in the physiological changes that occur in the body as altitude increases. As divers ascend to high altitudes, the ambient pressure decreases, leading to lower partial pressures of oxygen in the air. This can result in altitude sickness, characterized by symptoms such as headaches, dizziness, and nausea.

Prophylactic drugs, such as acetazolamide, can help stimulate breathing and improve oxygenation, effectively reducing the risk and severity of altitude sickness. These medications work by enhancing the body’s acclimatization process to high altitudes, allowing individuals to adjust more effectively and mitigate the adverse effects associated with low oxygen levels.

In contrast, while increasing the oxygen supply can help manage some effects of altitude, it doesn't necessarily prevent altitude sickness itself, particularly in the absence of supplemental oxygen systems. Extended decompression stops are primarily designed to manage the risks associated with ascending from depth to avoid decompression sickness, not altitude sickness specifically. Additional divers do not address the physiological challenges posed by altitude, as the risk of altitude sickness is an individual concern rather than a matter of dive team size.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy